Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.76)
# 1,792
Out of 4,832 analysts
27
Total ratings
58.33%
Success rate
16.71%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $1.15 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $308.07 | +11.66% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $10.14 | +427.61% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $33.37 | +19.87% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $15.99 | +87.62% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $3.39 | +150.74% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $9.03 | +77.19% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $3.19 | +33,438.97% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.19 | +12,088.66% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $2.87 | +1,677.00% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $4.99 | +220.64% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.22 | +1,297.52% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $308.07
Upside: +11.66%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $10.14
Upside: +427.61%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $33.37
Upside: +19.87%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $15.99
Upside: +87.62%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $3.39
Upside: +150.74%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $9.03
Upside: +77.19%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $3.19
Upside: +33,438.97%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.19
Upside: +12,088.66%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $2.87
Upside: +1,677.00%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $4.99
Upside: +220.64%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.22
Upside: +1,297.52%